Recent patents on therapeutic applications of the transcription factor decoy approach.

about

Entropic Enhancement of Protein-DNA Affinity by Oxygen-to-Sulfur Substitution in DNA Phosphate.Regulation of neural stem cell differentiation by transcription factors HNF4-1 and MAZ-1.

P2860

Q36043829-BD6C51DA-12F3-4364-901B-64E420BCC6B3 Q38322072-CFF01D55-F8B0-48C8-B836-BC583EE2B378

P2860

Recent patents on therapeutic applications of the transcription factor decoy approach.

Item

http://www.wikidata.org/entity/Q37948111

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Recent patents on therapeutic applications of the transcription factor decoy approach.

@en

Recent patents on therapeutic applications of the transcription factor decoy approach.

@nl

type

Item

label

Recent patents on therapeutic applications of the transcription factor decoy approach.

@en

Recent patents on therapeutic applications of the transcription factor decoy approach.

@nl

prefLabel

Recent patents on therapeutic applications of the transcription factor decoy approach.

@en

Recent patents on therapeutic applications of the transcription factor decoy approach.

@nl

P1476

Recent patents on therapeutic applications of the transcription factor decoy approach.

@en

P2860

MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13

Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?

NF-kappaB at the crossroads of life and death

Distamycin A affects the stability of NF-kappaB p50-DNA complexes in a sequence-dependent manner.

Nuclear factor-kappa B decoy suppresses nerve injury and improves mechanical allodynia and thermal hyperalgesia in a rat lumbar disc herniation model.

Therapeutic applications of transcription factor decoy oligonucleotides

The current state of chromatin immunoprecipitation.

Role of the NF-kappaB pathway in the pathogenesis of human disease states.

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome.

P304

1755-1771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2011.629605

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Gambari

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22017413

http://www.w3.org/2001/XMLSchema#string

P921

patent

Recent patents on therapeutic applications of the transcription factor decoy approach.

about

P2860

P2860

Recent patents on therapeutic applications of the transcription factor decoy approach.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921